Study drug for aggressive brain tumor after surgery
Part of Cancer clinical trials.
This trial tests an “antisecretory factor” treatment in people with grade 4 glioblastoma (or astrocytoma). It aims to see whether it can improve outcomes when used alongside planned cancer treatments after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed by pathology with glioblastoma or astrocytoma grade 4
- You are between 18 and 75 years old
- You had surgery with tumor removal (resection), not just a small sample
- Your treatment plan includes chemotherapy with radiation, or chemotherapy alone (not radiation only)
- You can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if Salovum, a special egg yolk product, can improve oxygen levels and reduce pressure and inflammation in the brain for people with a suspected glioblastoma. It involves a biopsy before treatment starts.
This trial tests whether two special food products (Salovum and SPC Flakes) can help reduce brain swelling caused by tumors. If you have a brain tumor with swelling and are already on steroids, you may be able to join.
This trial tests a more intense chemotherapy plan for people with glioblastoma who had only partial removal of their tumor or whose tumor grew back quickly. The goal is to see if this approach can improve outcomes.
This study looks at how your immune system reacts to brain tumor surgery and standard treatment, using a special dye to help the surgeon see the tumor better. It aims to find out if this approach can improve outcomes for people with glioblastoma.
This trial tests an oral drug called gallium maltolate for people whose glioblastoma (a type of brain cancer) has returned after standard treatment. The drug is given by mouth and may help slow tumor growth.
This study looks at how different treatments and patient factors affect outcomes in people with glioblastoma, an aggressive type of brain tumor. By joining, you help researchers learn which approaches work best, which could improve care for future patients.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.